Navigation Links
Timothy T. Goodnow, Ph.D., Joins Sensors for Medicine and Science, Inc. Board of Directors
Date:11/8/2010

GERMANTOWN, Md., Nov. 8, 2010 /PRNewswire-USNewswire/ -- Sensors for Medicine and Science, Inc., a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced that Tim Goodnow, Ph.D., will be joining the Board of Directors and working with the Company as a Consultant.

Dr. Goodnow was most recently with Abbott Diabetes Care where he was the Vice President, Technical Operations.  Prior to that, he held positions at TheraSense, Verax Biomedical, Dade Behring and Baxter Healthcare.  Dr. Goodnow has led the successful development of a number of FDA approved glucose monitoring systems.  He holds a Ph.D. and B.S. in Chemistry from the University of Miami.

"I am thrilled to be joining the Sensors for Medicine and Science Board of Directors," said Dr. Goodnow.  "I look forward to working with the team to successfully launch these innovative new devices and am excited about the improvements they can make for people with diabetes."

"Tim is a great addition to our Board," stated Stephen P. DeFalco, Executive Chairman.  "His experience and track record bringing innovative glucose monitoring devices to market will help accelerate our efforts."

Sensors for Medicine and Science's lead product is a long-term, implanted continuous glucose monitor based on its unique and proprietary sensor technology.  This product includes a miniaturized sensor and an external reader.  The sensor is inductively powered and remotely interrogated, so there is no battery on-board and no wires connecting the implanted sensor to the external reader.  As a result, after implantation, the sensor functions noninvasively, painlessly, automatically, and continuously.  The Company is also developing a version of the technology to support efforts for glycemic control of patients in an Intensive Care Unit setting.

About Sensors for Medicine and Science, Inc.

Sensors for Medicine and Science, Inc. is pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes.  The Company believes that its long-term, continuous glucose monitor technology has the potential to replace regular finger stick monitoring.  

Sensors for Medicine and Science, Inc. has also developed oxygen sensor technology, with potential applications in areas such as metabolic monitoring (weight management), respiratory and cardiac disease.  In addition, the Company sells its oxygen sensors as a component to original equipment manufacturers.

For more information about Sensors for Medicine and Science, Inc., please visit http://www.s4ms.com.


'/>"/>
SOURCE Sensors for Medicine and Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care
2. HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference
3. Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer
4. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
5. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
6. CORD:USE Cord Blood Bank Congratulates Team Member Hal Broxmeyer, Ph.D., on his Election as President of the American Society of Hematology
7. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
8. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
9. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
10. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
11. Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... DALLAS , April 19, 2017 /PRNewswire/ ... that the first patients in Nashville ... in the Lower Esophageal Sphincter Stimulation for GERD (LESS ... device designed to provide long-term reflux control by restoring ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to compare student test score performance for the 2015-16 school year across Wisconsin’s ... voucher programs. Though it highlights important patterns in student test score performance, the ...
(Date:4/25/2017)... Switzerland (PRWEB) , ... April 25, 2017 , ... ... innovation targets, they rely on contracted partners to help with process innovation in ... of combined drug formulation experience along with state-of-the-art analytical equipment in support of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to ... of acute or chronic problems, I focus on preventative care with all my patients to ... have any questions, always feel free to contact my office and my trained staff will ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
Breaking Medicine News(10 mins):